Nevada’s nascent medical marijuana industry faces strict testing and custody requirements, hurdles many struggling companies have been unable to overcome, but GrowBLOX Sciences continues to defy the trend, announcing their 30,000 sq. ft. Cultivation Labs are set to finish construction and begin operations before the end of the year.
The cannabis market is a complicated beast, a brand new industry, ripe with potential riches yet fraught with perilous dangers, impediments varying in origin and severity from state to state.
In a handful of States everything is rosy, with medical marijuana markets functioning smoothly and helping patients, while in a handful more recreational cannabis laws are going over like gangbusters. Meanwhile less fortunate States aren’t faring quite as well, with convoluted legislation or unexpectedly strict testing requirements keeping cannabis from reaching the market. Luckily for GrowBLOX Sciences, Nevada is a prime example of the latter.
This is good news for GrowBLOX Sciences and their investors because, since their inception, they’ve been approaching cannabis cultivation from a biotech background, and anything less than a scientifically validated, safe product was never going to be an option. At this point, the only thing precluding their medicinal cannabis making it to market, is cultivating a crop for commercial harvest.